about
Diabetes, insulin and cancer risk.Proteomic identification of fat-browning markers in cultured white adipocytes treated with curcumin.Delayed clearance of triglyceride-rich lipoproteins in young, healthy obese subjectsNutritional influences on epigenetics and age-related disease.Treatment of the obese patient in primary care: targeting and meeting goals and expectations.Yirui Capsules Alleviate Atherosclerosis by Improving the Lipid Profile and Reducing Inflammation in Apolipoprotein E-Deficient Mice.Protective Capacity of Statins during Pneumonia Is Dependent on Etiological Agent and Obesity.
P2860
Q35906970-47439EC6-1B63-4C1A-9F29-9D9729914FF6Q35935901-DA49932C-34DB-4AE9-800D-B729472AF83EQ37418124-316D6EB1-2EA0-4D34-888A-02BC6AA4545FQ37952442-9DDFF056-F1B3-47BA-B6B0-80C6DD515F47Q38151449-6E696C77-822F-465B-985E-A4A5D09D2EACQ48140748-572451B9-161D-4C02-BBE2-5B6FD9781BF9Q54263540-956C95DD-FC3D-47EA-AA1C-15BC72A4E4A7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment of lipid disorders in obesity.
@en
Treatment of lipid disorders in obesity.
@nl
type
label
Treatment of lipid disorders in obesity.
@en
Treatment of lipid disorders in obesity.
@nl
prefLabel
Treatment of lipid disorders in obesity.
@en
Treatment of lipid disorders in obesity.
@nl
P2860
P356
P1476
Treatment of lipid disorders in obesity.
@en
P2093
Serena Tonstad
P2860
P304
P356
10.1586/ERC.11.83
P577
2011-08-01T00:00:00Z